Viewing Study NCT05400603

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2026-03-01 @ 9:59 AM
Study NCT ID: NCT05400603
Status: RECRUITING
Last Update Posted: 2025-09-15
First Post: 2022-05-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
Sponsor: Emory University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroblastoma View
None Refractory Neuroblastoma View
None Relapsed Neuroblastoma View
None Relapsed Osteosarcoma View
None Refractory Osteosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gamma Delta T Cells View
None Dinutuximab View
None Temozolomide View
None Zoledronate View
None Irinotecan View
None GD2 View
None chemoimmunotherapy View